Hansa Biopharma AB

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -54.47% vs 146.75% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -18.97% vs -11.26% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "34.60",
          "val2": "76.00",
          "chgp": "-54.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-142.10",
          "val2": "-124.70",
          "chgp": "-13.95%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "55.90",
          "val2": "64.60",
          "chgp": "-13.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-196.30",
          "val2": "-165.00",
          "chgp": "-18.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-4,110.80%",
          "val2": "-1,641.20%",
          "chgp": "-246.96%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 29.77% vs 27.74% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 33.83% vs 2.95% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "222.30",
          "val2": "171.30",
          "chgp": "29.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-483.80",
          "val2": "-591.40",
          "chgp": "18.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "122.50",
          "val2": "121.40",
          "chgp": "0.91%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-59.40",
          "val2": "-12.80",
          "chgp": "-364.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-534.10",
          "val2": "-807.20",
          "chgp": "33.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2,351.10%",
          "val2": "-3,615.70%",
          "chgp": "126.46%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

34.60

76.00

-54.47%

Operating Profit (PBDIT) excl Other Income

-142.10

-124.70

-13.95%

Interest

55.90

64.60

-13.47%

Exceptional Items

0.00

0.00

Consolidate Net Profit

-196.30

-165.00

-18.97%

Operating Profit Margin (Excl OI)

-4,110.80%

-1,641.20%

-246.96%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -54.47% vs 146.75% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is -18.97% vs -11.26% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

222.30

171.30

29.77%

Operating Profit (PBDIT) excl Other Income

-483.80

-591.40

18.19%

Interest

122.50

121.40

0.91%

Exceptional Items

-59.40

-12.80

-364.06%

Consolidate Net Profit

-534.10

-807.20

33.83%

Operating Profit Margin (Excl OI)

-2,351.10%

-3,615.70%

126.46%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 29.77% vs 27.74% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 33.83% vs 2.95% in Dec 2024

All Annual Results